EA201790772A1 - Фармацевтическая композиция, содержащая бета-блокатор и ингибитор ангиотензинпревращающего фермента - Google Patents

Фармацевтическая композиция, содержащая бета-блокатор и ингибитор ангиотензинпревращающего фермента

Info

Publication number
EA201790772A1
EA201790772A1 EA201790772A EA201790772A EA201790772A1 EA 201790772 A1 EA201790772 A1 EA 201790772A1 EA 201790772 A EA201790772 A EA 201790772A EA 201790772 A EA201790772 A EA 201790772A EA 201790772 A1 EA201790772 A1 EA 201790772A1
Authority
EA
Eurasian Patent Office
Prior art keywords
blocker
pharmaceutical composition
composition containing
converting enzyme
inhibitor
Prior art date
Application number
EA201790772A
Other languages
English (en)
Other versions
EA032808B1 (ru
Inventor
Жилль Фонкнехтен
Original Assignee
Ле Лаборатуар Сервье
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52345359&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201790772(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ле Лаборатуар Сервье filed Critical Ле Лаборатуар Сервье
Publication of EA201790772A1 publication Critical patent/EA201790772A1/ru
Publication of EA032808B1 publication Critical patent/EA032808B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Фиксированная фармацевтическая композиция, содержащая бета-блокатор, бисопролол и ингибитор ангиотензинпревращающего фермента, периндоприл, и применение указанной композиции для лечения или профилактики сердечно-сосудистых заболеваний, в особенности артериальной гипертензии, стабильной ишемической болезни сердца или хронической сердечной недостаточности.
EA201790772A 2014-11-05 2015-11-04 Дозированная лекарственная форма, содержащая бисопролол и периндоприл EA032808B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1460654A FR3027803B1 (fr) 2014-11-05 2014-11-05 Composition pharmaceutique comprenant un betabloquant et un inhibiteur de l'enzyme de conversion
PCT/FR2015/052975 WO2016071631A1 (fr) 2014-11-05 2015-11-04 Composition pharmaceutique comprenant le bisoprolol et le périndopril

Publications (2)

Publication Number Publication Date
EA201790772A1 true EA201790772A1 (ru) 2017-09-29
EA032808B1 EA032808B1 (ru) 2019-07-31

Family

ID=52345359

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201790772A EA032808B1 (ru) 2014-11-05 2015-11-04 Дозированная лекарственная форма, содержащая бисопролол и периндоприл

Country Status (24)

Country Link
EP (1) EP3215130B1 (ru)
CY (1) CY1123322T1 (ru)
DK (1) DK3215130T3 (ru)
EA (1) EA032808B1 (ru)
ES (1) ES2811904T3 (ru)
FR (1) FR3027803B1 (ru)
GE (1) GEP20196989B (ru)
HR (1) HRP20201518T1 (ru)
HU (1) HUE051947T2 (ru)
LT (1) LT3215130T (ru)
MA (1) MA40915B1 (ru)
MX (1) MX2017005848A (ru)
MY (1) MY187357A (ru)
PH (1) PH12017500786B1 (ru)
PL (1) PL3215130T3 (ru)
PT (1) PT3215130T (ru)
RS (1) RS60657B1 (ru)
RU (1) RU2702362C2 (ru)
SG (2) SG11201703550SA (ru)
SI (1) SI3215130T1 (ru)
TN (1) TN2017000170A1 (ru)
UA (1) UA122131C2 (ru)
WO (1) WO2016071631A1 (ru)
ZA (1) ZA201703078B (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2024004714A (es) 2021-10-20 2024-05-10 Servier Lab Nuevas sales de trimetazidina.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003092729A1 (de) 2002-05-03 2003-11-13 Hexal Ag Stabile pharmazeutische formulierung für eine kombination aus einem statin mit einem ace-hemmer
WO2007010501A2 (en) * 2005-07-22 2007-01-25 Ranbaxy Laboratories Limited A pharmaceutical composition comprising a combination of beta blocker and an ace inhibitor
HU230877B1 (hu) * 2008-09-30 2018-11-29 EGIS Gyógyszergyár NyR Stabil kombinációs gyógyszerkészítmény
AU2010242938A1 (en) * 2009-04-30 2011-11-17 Dr. Reddy's Laboratories Ltd. Fixed dose drug combination formulations
WO2011138772A1 (en) 2010-05-06 2011-11-10 Cal International Limited A pharmaceutical composition comprising aspirin and bisoprolol

Also Published As

Publication number Publication date
CY1123322T1 (el) 2021-12-31
HRP20201518T1 (hr) 2020-12-11
UA122131C2 (uk) 2020-09-25
ES2811904T3 (es) 2021-03-15
LT3215130T (lt) 2020-08-25
PH12017500786A1 (en) 2017-10-02
RU2017115341A (ru) 2018-11-05
WO2016071631A1 (fr) 2016-05-12
FR3027803A1 (fr) 2016-05-06
EA032808B1 (ru) 2019-07-31
SG10201903656RA (en) 2019-05-30
SG11201703550SA (en) 2017-06-29
MA40915B1 (fr) 2020-08-31
MY187357A (en) 2021-09-22
EP3215130A1 (fr) 2017-09-13
PL3215130T3 (pl) 2020-11-16
EP3215130B1 (fr) 2020-07-08
SI3215130T1 (sl) 2020-11-30
PH12017500786B1 (en) 2017-10-02
PT3215130T (pt) 2020-08-26
MX2017005848A (es) 2017-06-27
FR3027803B1 (fr) 2018-02-09
GEP20196989B (en) 2019-07-10
HUE051947T2 (hu) 2021-03-29
DK3215130T3 (da) 2020-09-21
TN2017000170A1 (fr) 2018-10-19
ZA201703078B (en) 2020-11-25
RU2017115341A3 (ru) 2019-05-21
RU2702362C2 (ru) 2019-10-08
RS60657B1 (sr) 2020-09-30

Similar Documents

Publication Publication Date Title
EA201790998A1 (ru) Иммуннорегуляторные агенты
EA201891057A1 (ru) Композиции и способы для ингибирования активности аргиназы
EA201790765A1 (ru) Производные спиродиамина в качестве ингибиторов альдостерон-синтазы
EA201891087A1 (ru) Ингибиторы ret
EA201790785A1 (ru) Производные тетрагидроизохинолина
EA201791867A1 (ru) Бициклические гетероциклы как ингибиторы fgfr4
EA201692437A1 (ru) Комбинация
EA201591509A1 (ru) Ингибиторы cdc7
EA201790170A1 (ru) Терапевтические соединения-ингибиторы
EA201691134A1 (ru) Новые ингибиторы глутаминазы
EA201691421A1 (ru) Гетероарилы и их применение
EA201390609A1 (ru) ПРОИЗВОДНЫЕ ГИДАНТОИНА, ПОЛЕЗНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ Kv3-КАНАЛОВ
MX2016014911A (es) Acidos hidroxamicos heterociclicos como inhibidores de proteina desacetilasa e inhibidores dobles de proteina desacetilasa-proteina cinasa, y metodos de uso de los mismos.
EA201791259A1 (ru) Производные пиперидина в качестве ингибиторов hdac1/2
EA201692091A1 (ru) Хиноксалиновые соединения и их применение
EA202091731A1 (ru) Ингибиторы аутотаксина и их применения
EA201692313A1 (ru) Производные индолизина в качестве ингибиторов фосфоинозитид-3-киназ
EA201791454A1 (ru) Лекарственные формы для трансдермального введения
BR112017000730B8 (pt) Derivados de pirrolidinona como inibidores de metap-2, e medicamentos
EA201791992A1 (ru) Ингибиторы грелин-o-ацилтрансферазы
EA201792000A1 (ru) Ингибиторы грелин-o-ацилтрансферазы
EA202091337A1 (ru) Ингибиторы гистонацетилтрансфераз семейства myst
EA201790445A1 (ru) Производные индолинона и их применение
EA201990095A1 (ru) КОНДЕНСИРОВАННЫЕ ТИОФЕНОВЫЕ ПРОИЗВОДНЫЕ, ПРИЕМЛЕМЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ NAPI-IIb
EA201790590A1 (ru) Гуманизированное моноклональное антитело, ингибирующее ферментативную активность сосудисто-эндотелиальной липазы